Treat-to-Target Outcomes and Measures of Treatment Success in Three Phase 3 Trials of Tapinarof Cream 1% Once Daily for Mild to Severe Plaque Psoriasis. J of Skin 2023, 7 (2), s124. https://doi.org/10.25251/skin.7.supp.124.